STO : BONEX.ST
$8.8 (4.0%)
STO
Torbjorn Skold
Medical - Devices
Healthcare
BONEX.ST
140
SE
SEK
0.01
5.44
4.44
2.60
0.00
$1.17B
11.66
15.88
57.12
3.99
$2.13
$142.15M
16.63%
23.35%
23.82%
19.10%
70.68
1.61
1.61
3/5
0 Analysts
%
53.02
5/9
$741.09M
$1.12B
$169.72M
$312.31M
No key metrics data available.
| Name | Title |
|---|---|
| Michael Wrang Mortensen | Executive Vice President of Global R&D and Operations |
| Torbjorn Skold | Chief Executive Officer |
| Michael Roth | GM & Executive VP of Commercial Operations of US |
| Anna Stegmark | Executive Vice President of Quality Management & Regulatory Affairs |
| Helena L. Brandt | Executive Vice President of Human Resources |
| Michael Diefenbeck | Executive Vice President of Medical & Clinical Affairs and Chief Medical Officer |
| Fergus MacLeod | GM & Executive Vice President of Commercial Operations of EUROW |
| Håkan Johansson | Chief Financial Officer |
| Annelie Aava Vikner | Executive Vice President of Global Marketing |
No votes yet today — be the first to share your view!
About Bonesupport Holding AB (publ) (STO:BONEX.ST) Stock
Bonesupport Holding AB (publ) is an orthobiologics company that specializes in the development and commercialization of injectable bioceramic bone graft substitutes. These products are utilized for treating bone voids and are available internationally, including in Europe and North America. Among its key offerings are CERAMENT Bone Void Filler, a synthetic, injectable, moldable, and drillable solution comprising hydroxyapatite, calcium sulfate, and the radio-contrast agent iohexol. Additionally, the company provides CERAMENT G, an injectable ceramic bone graft substitute infused with gentamicin, and CERAMENT V, a synthetic bone void filler containing vancomycin. Bonesupport is also advancing preclinical product candidates focused on promoting bone regrowth. These future solutions are being ... developed for applications such as trauma, revision arthroplasty, chronic osteomyelitis, oncology, and bone and foot infections related to diabetes. Founded in 1999, the company maintains its headquarters in Lund, Sweden.
Frequently Asked Questions
What is the current Bonesupport Holding AB (publ) (BONEX.ST) stock price?
Bonesupport Holding AB (publ)(STO:BONEX.ST) stock price is $229 in the last trading session. During the trading session, BONEX.ST stock reached the peak price of $329.2 while $165 was the lowest point it dropped to. The percentage change in BONEX.ST stock occurred in the recent session was 4.0% while the dollar amount for the price change in BONEX.ST stock was $8.8.
BONEX.ST's industry and sector of operation?
The STO listed BONEX.ST is part of Medical - Devices industry that operates in the broader Healthcare sector.
Who are the executives of BONEX.ST?
Michael Wrang Mortensen
| Executive Vice President of Global R&D and Operations
Torbjorn Skold
| Chief Executive Officer
Michael Roth
| GM & Executive VP of Commercial Operations of US
Anna Stegmark
| Executive Vice President of Quality Management & Regulatory Affairs
Helena L. Brandt
| Executive Vice President of Human Resources
How many employees does BONEX.ST have?
Number of BONEX.ST employees currently stands at 140. BONEX.ST operates from Scheelevägen 19, Lund, SN 223 70, SE.
Link for BONEX.ST official website?
Official Website of BONEX.ST is: https://www.bonesupport.com
How do I contact BONEX.ST?
BONEX.ST could be contacted at phone #46 4 62 86 53 70 and can also be accessed through its website. BONEX.ST operates from Scheelevägen 19, Lund, SN 223 70, SE.
How many shares of BONEX.ST are traded daily?
The average number of BONEX.ST shares traded daily for last 3 months was 224.41K.
What is the market cap of BONEX.ST currently?
The market value of BONEX.ST currently stands at $15B with its latest stock price at $229